Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours
Lay Description
The purpose of this study is to determine whether accelerated BEP chemotherapy is more effective than standard BEP chemotherapy in males with intermediate and poor-risk metastatic germ cell tumours.
Category
- Cancers and Other Neoplasms
- Child Health
- Genetics
- Wounds and Injuries
- Germ Cell Tumors of the CNS
- IRB Number
- 20180851HU
- NCT Number
- ct.gov registration not required
- Open to Enrollment
- No
Eligibility
- Eligible Ages
- 11 Years - 45 Years
- Eligible Genders
- Male
- Accepts Healthy Volunteers
- No
Inclusion Criteria
Exclusion Criteria
Study Design
Study Contact
Principal Investigator
Gail Tomlinson